Mega Lifesciences Public Company Limited (MEGA-R) — Capital Reinvestment Ratio
Mega Lifesciences Public Company Limited (MEGA-R) has a Capital Reinvestment Ratio of 0.22x as of June 2025, meaning it reinvests 0% of its operating cash flow (฿461.26 Million) in capital expenditures (฿100.93 Million). See Mega Lifesciences Public Company Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Mega Lifesciences Public Company Limited Capital Reinvestment Ratio (2011–2024)
This chart tracks Mega Lifesciences Public Company Limited's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Mega Lifesciences Public Company Limited (2011–2024)
Year-by-year Capital Reinvestment Ratio for Mega Lifesciences Public Company Limited from 2011 to 2024. For live market cap and broader valuation context, see MEGA-R market cap.
| Year | Reinvestment Ratio | Operating CF (THB) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ฿2.40 Billion | ฿257.29 Million | ▼ -29.7% |
| 2023 | 0.15x | ฿1.93 Billion | ฿293.57 Million | ▼ -2.7% |
| 2022 | 0.16x | ฿2.00 Billion | ฿312.74 Million | ▲ +167.3% |
| 2021 | 0.06x | ฿2.73 Billion | ฿159.78 Million | ▼ -62.6% |
| 2020 | 0.16x | ฿1.63 Billion | ฿255.07 Million | ▼ -56.7% |
| 2019 | 0.36x | ฿1.50 Billion | ฿540.82 Million | ▼ -55.8% |
| 2018 | 0.82x | ฿919.36 Million | ฿751.90 Million | ▲ +232.7% |
| 2017 | 0.25x | ฿927.00 Million | ฿227.85 Million | ▲ +3.8% |
| 2016 | 0.24x | ฿1.26 Billion | ฿298.39 Million | ▼ -25.4% |
| 2015 | 0.32x | ฿609.12 Million | ฿193.22 Million | ▼ -10.9% |
| 2014 | 0.36x | ฿614.22 Million | ฿218.67 Million | ▼ -58.7% |
| 2013 | 0.86x | ฿465.77 Million | ฿401.97 Million | ▼ -53.1% |
| 2012 | 1.84x | ฿342.02 Million | ฿629.56 Million | ▲ +513.5% |
| 2011 | 0.30x | ฿266.67 Million | ฿80.01 Million | — |